What is the ROE (Return on Equity) of Liquidia this year?
The ROE of Liquidia this year is -1.66 undefined.
Liquidia ROE 2024
Liquidia ROE
-1.66
Liquidia Dividend yield
Ticker
LQDA
ISIN
US53635D2027
WKN
A2JRNS
In 2024, Liquidia's return on equity (ROE) was -1.66, a 265.81% increase from the -0.45 ROE in the previous year.
Liquidia Aktienanalyse
What does Liquidia do?
Liquidia Corp is a biopharmaceutical company specializing in the development of novel therapeutic products using an advanced technology called Liqutex. This technology allows for precise control over the size, shape, and surface properties of particles, enabling targeted release of active ingredients in the body. The company was founded in 2004 as a spin-off from the University of North Carolina at Chapel Hill. It has been supported by prominent investors such as PPD, Inc. and New Enterprise Associates to advance the development of new drugs. Liquidia's business model is based on creating a comprehensive product portfolio with applications in various therapeutic areas, including immunology, oncology, infectious diseases, and pulmonary hypertension. The idea is to cover a wide range of applications with the Liqutex technology to increase competitiveness in the market. To achieve this, Liquidia has formed partnerships with other companies and research institutions to advance therapeutic development. For example, it collaborates with GlaxoSmithKline on the development of vaccines for pertussis and influenza. Another important aspect of Liquidia's business model is the creation of differentiated products that address a broader range of patient needs. For instance, the company has developed a novel drug combination for the treatment of pulmonary hypertension, which exhibits better efficacy and tolerability due to its specific formulation. In addition to its focus on therapeutic applications, Liquidia has also developed a range of products for industrial use. For example, it has a specialized technology for producing high-quality nanoparticles for the electronics industry. Overall, Liquidia stands out for its versatility and innovative solutions. The company has a unique technology platform that allows it to create differentiated products for both the medical and industrial sectors. Supported by an experienced management team and prominent investors, Liquidia is pursuing a holistic growth strategy to maintain a leading role in the biotechnology industry. Liquidia Corp is a biopharmaceutical company specializing in the development of novel therapeutic products using an advanced technology called Liqutex. The company was founded in 2004 as a spin-off from the University of North Carolina at Chapel Hill and has received support from investors such as PPD, Inc. and New Enterprise Associates. Liquidia's business model focuses on creating a comprehensive product portfolio with applications in various therapeutic areas, including immunology, oncology, infectious diseases, and pulmonary hypertension. The company aims to cover a wide range of applications with its Liqutex technology to increase competitiveness in the market. To achieve this, Liquidia has formed partnerships with other companies and research institutions, such as GlaxoSmithKline, to advance therapeutic development. Additionally, Liquidia prioritizes the creation of differentiated products that address a broader range of patient needs, such as a novel drug combination for the treatment of pulmonary hypertension. In addition to therapeutic applications, Liquidia has also developed products for industrial use, such as specialized technology for producing nanoparticles for the electronics industry. Liquidia distinguishes itself through its versatility and innovative solutions, with a unique technology platform and a holistic growth strategy supported by an experienced management team and prominent investors. Liquidia ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Liquidia's Return on Equity (ROE)
Liquidia's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Liquidia's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Liquidia's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Liquidia’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Liquidia Stock
How has the Return on Equity (ROE) of Liquidia developed compared to the previous year?
The ROE of Liquidia has increased by 265.81% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Liquidia?
A high ROE indicates that Liquidia generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Liquidia?
A low ROE can indicate that Liquidia is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Liquidia affect the company?
A change in ROE (Return on Equity) of Liquidia can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Liquidia?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Liquidia?
Some factors that can influence Liquidia's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Liquidia pay?
Over the past 12 months, Liquidia paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Liquidia is expected to pay a dividend of 0 USD.
What is the dividend yield of Liquidia?
The current dividend yield of Liquidia is .
When does Liquidia pay dividends?
Liquidia pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Liquidia?
Liquidia paid dividends every year for the past 0 years.
What is the dividend of Liquidia?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Liquidia located?
Liquidia is assigned to the 'Health' sector.
Wann musste ich die Aktien von Liquidia kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Liquidia from 5/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/29/2024.
When did Liquidia pay the last dividend?
The last dividend was paid out on 5/29/2024.
What was the dividend of Liquidia in the year 2023?
In the year 2023, Liquidia distributed 0 USD as dividends.
In which currency does Liquidia pay out the dividend?
The dividends of Liquidia are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Liquidia
Our stock analysis for Liquidia Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Liquidia Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
